Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Desiree Watson"'
Autor:
Dean C. Luehrs, Sangram S. Sisodia, Alex E. Roher, Mark R. Emmerling, M. Desiree Watson, Daniel C. Brune, Tyler A. Kokjohn, Yu Min Kuo, Walter M. Kalback, Nicole Weiss, Matthias Staufenbiel, John Lopez
Publikováno v:
Biochemistry. 41:922-928
The amyloid (Abeta) peptides generated in Hsiao's APP Tg2576 transgenic (Tg) mice are physically and chemically distinct from those characteristic of Alzheimer's disease (AD). Transgenic mouse Abeta peptides were purified using sequential size-exclus
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1502(1):158-171
Complement proteins are integral components of amyloid plaques and cerebral vascular amyloid in Alzheimer brains. They can be found at the earliest stages of amyloid deposition and their activation coincides with the clinical expression of Alzheimer
Autor:
Walter Michael, Cuiman Cai, M. Desiree Watson, Lori M. Evans, Kevin K.W. Wang, Mark R. Emmerling, John L. Gilmore, Sheryl J. Hays, Lakshmi S. Narasimhan, Juan C. Jaen, Janet S. Plummer, Rathna Nath
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 9:815-820
A series of 2-sulfonyl-4H-3,1-benzoxazinones was prepared that inhibit C1r protease in vitro. Several compounds were found to be selective for C1r verses the related serine protease trypsin. Selected compounds demonstrated functional activity in a he
Autor:
Desiree Watson, John L. Gilmore, Juan C. Jaen, Daniel Stafford, Nilam Amin, Rathna Nath, Ravi Nadimpalli, Kevin K.W. Wang, Bradley William Caprathe, Sheryl J. Hays, Kadee J. Raser, Walter Michael, Mark R. Emmerling
Publikováno v:
Journal of Medicinal Chemistry. 41:1060-1067
A series of 2-amino-4H-3,1-benzoxazin-4-ones have been synthesized and evaluated as inhibitors of the complement enzyme C1r. C1r is a serine protease at the beginning of the complement cascade, and complement activation by beta-amyloid may represent
Publikováno v:
Amyloid. 4:147-156
Complement activation and its deposition on β-amyloid plaques in Alzheimer's Disease (AD) brains correlates with the development of AD dementia. Results from immunocytochemical studies suggest that the appearance of complement activation in AD brain
Autor:
Mark R. Emmerling, W. Blaine Stine, Linda M. Rowse, Chera Esh, Tyler A. Kokjohn, Eduardo M. Castaño, E. Sander Connolly, Dean C. Luehrs, Yu Min Kuo, Desiree Watson, David J. Pinsky, Yuri L. Lyubchenko, Alex E. Roher
Publikováno v:
Neurological research. 27(8)
Extracellular fibrillar amyloid deposits are prominent and universal Alzheimer's disease (AD) features, but senile plaque abundance does not always correlate directly with the degree of dementia exhibited by AD patients. The mechanism(s) and dynamics
Autor:
Alex E. Roher, Tyler A. Kokjohn, Douglas G. Walker, Jacqueline Anthony, Yu Min Kuo, Walter M. Kalback, Nicole Weiss, Desiree Watson, Thomas G. Beach, Dean C. Luehrs, Lucia I. Sue, Mark R. Emmerling, Warren J. Goux
Publikováno v:
Biochemistry. 41(37)
Relative to the gray matter, there is a paucity of information regarding white matter biochemical alterations and their contribution to Alzheimer's disease (AD). Biochemical analyses of AD white matter combining size-exclusion, normal phase, and gas
Autor:
Walter, Kalback, M Desiree, Watson, Tyler A, Kokjohn, Yu-Min, Kuo, Nicole, Weiss, Dean C, Luehrs, John, Lopez, Daniel, Brune, Sangram S, Sisodia, Matthias, Staufenbiel, Mark, Emmerling, Alex E, Roher
Publikováno v:
Biochemistry. 41(3)
The amyloid (Abeta) peptides generated in Hsiao's APP Tg2576 transgenic (Tg) mice are physically and chemically distinct from those characteristic of Alzheimer's disease (AD). Transgenic mouse Abeta peptides were purified using sequential size-exclus
Autor:
Tyler A. Kokjohn, Mark R. Emmerling, M. Desiree Watson, Amina S. Woods, Yu Min Kuo, Walter M. Kalback, Robert J. Cotter, Lucia I. Sue, Thomas G. Beach, Alex E. Roher
The levels of amyloid-beta40 (Abeta40) and Abeta42 peptides were quantified in temporalis muscles and brain of neuropathologically diagnosed Alzheimer disease (AD) and of nondemented individuals. This was achieved by using a novel analytical approach
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abfb29d133c9d0badb5789fb3b0eef4f
https://europepmc.org/articles/PMC1876838/
https://europepmc.org/articles/PMC1876838/
Autor:
Karl L. Brown, Taraneh Haske, M. Desiree Watson, Kathryn Spiegel, Charlotte Raby, Harry LeVine, Mark R. Emmerling, Lori M. Evans
Publikováno v:
Neurobiology of Aging. 21:90